While in training, I found great fulfillment in caring for patients with cancer, seeing their strength and resolve and trying to match this in my determination to give them the best possible treatment.

I was particularly attracted to radiation oncology due to my background in physics and the multitude of options radiation provides to treat patients with cancer. I have special interests in brachytherapy (low-dose and high-dose rates), as well as the protection of normal tissue during radiation therapy.

Since I believe all patients have unique stories to tell, my goal is to understand their individual stories – and then to discuss and tailor their radiation and cancer care. I love my work and feel privileged to support patients during the very difficult – and often rewarding – time of cancer treatment and follow-up.

Conditions I Treat

- Genitourinary cancers (prostate, bladder, kidney, testicular, etc.)
- Gynecologic cancers (endometrial, cervical, etc.)
- General radiation oncology

Certified Specialties

Radiation Oncology - American Board of Radiology

Faculty Appointments

Associate Professor - Department of Radiation Oncology (SMD)

Credentials

Residency & Fellowship

Residency, Radiation Oncology, University of Rochester Medical Center. 2009 - 2013

Internship, Internal Medicine, St. Louis University School of Medicine/Medical Center. 2008 - 2009

Education

MD | University of Rochester School of Medicine/Dentistry (USA). 2008

Awards

Educator of the Year. 2015

RSNA Roentgen Resident/Fellow Research Award. 2012

RSNA Roentgen Resident/Fellow Research Award. 2008

Research

Clinical Trials

Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)

Lead Researcher: Kevin Charles Bylund

This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone...

Publications

Journal Articles

Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Kerns SL; Amidon Morlang A; Lee SM; Peterson DR; Marples B; Zhang H; Bylund K; Rosenzweig D; Hall W; De Ruyck K; Rosenstein BS; Stock RG; Gómez-Caamaño A; Vega A; Sosa-Fajardo P; Taboada-Valladares B; Aguado-Barrera ME; Parker C; Veldeman L; Fonteyne V; Bultijnck R; Talbot CJ; Symonds RP; Johnson K; Rattay T; Webb A; Lambrecht M; de Ruysscher D; Vanneste B; Choudhury A; Elliott RM; Sperk E; Herskind C; Veldwijk MR; Rancati T; Avuzzi B; Valdagni R; Azria D; Farcy Jacquet MP; Chang-Claude J; et al.

Radiother Oncol. 2022; 168: 75-82.

Radiologically occult lung cancer curatively treated with high-dose rate endobronchial brachytherapy

Singh DP; Aujla K; Nead M; Bylund K.

J Clin Imaging Sci. 2021; 11: 45.

Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial

Ryan Wolf J; Gewandter JS; Bautista J; Heckler CE; Strasser J; Dyk P; Anderson T; Gross H; Speer T; Dolohanty L; Bylund K; Pentland AP; Morrow GR.

Support Care Cancer. 2020; 28(7): 3303-3311.

Building a High-Dose-Rate Prostate Brachytherapy Program With Real-Time Ultrasound-Based Planning: Initial Safety, Quality, and Outcome Results

Zhang H; Kang S; Ali N; Baran A; Bylund K; Gentile D; Previte G; Matloubieh A; Gray A; Marou N.

Adv Radiat Oncol. 2020; 5(3): 388-395.

Prognostic Significance of Sites of Visceral Metastatic Disease in Prostate Cancer: A Population-based Study of 12,180 Patients

Budnik J; Suri J; Bates JE; Bylund KC; Milano MT.

Clin Genitourin Cancer. 2019; 17(4): 260-267.

A Festschrift in Honor of Edward M. Messing, MD, FACS.

Joseph JV; Brasacchio R; Fung C; Reeder J; Bylund K; Sahasrabudhe D; Yeh SY; Ghazi A; Fultz P; Rubens D; Wu G; Singer E; Schwarz E; Mohile S; Mohler J; Theodorescu D; Lee YF; Okunieff P; McConkey D; Rashid H; Chang C; Fradet Y; Guru K; Kukreja J; Sufrin G; Lotan Y; Bailey H; Noyes K; Schwartz S; Rideout K; Bratslavsky G; Campbell SC; Derweesh I; Abrahamsson PA; Soloway M; Gomella L; Golijanin D; Svatek R; Frye T; Lerner S; Palapattu G; Wilding G; Droller M; Trump D.

Bladder Cancer. 2018; 4(suppl 1): S1-S43.

Is there a subset of patients with recurrent cancer in the vagina who are not candidates for interstitial brachytherapy that can be treated with multichannel vaginal brachytherapy using graphic optimization?

Singh DP, Bylund KC, Matloubieh A, Mazloom A, Gray A, Sidhu R, Barrette L, Chen Y

Journal of contemporary brachytherapy.. 2015 April 7 (2):135-41. Epub 04/28/2015.

Bladder cancer in the elderly patient: challenges and solutions.

Guancial EA, Roussel B, Bergsma DP, Bylund KC, Sahasrabudhe D, Messing E, Mohile SG, Fung C

Clinical interventions in aging.. 2015 10 :939-49. Epub 06/10/2015.

Split-course palliative radiotherapy for advanced non-small cell lung cancer.

Metcalfe SK, Milano MT, Bylund K, Smudzin T, Rubin P, Chen Y

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.. 2010 February 5 (2):185-90. Epub 1900 01 01.

Analysis of interfraction prostate motion using megavoltage cone beam computed tomography.

Bylund KC, Bayouth JE, Smith MC, Hass AC, Bhatia SK, Buatti JM

International journal of radiation oncology, biology, physics.. 2008 November 172 (3):949-56. Epub 1900 01 01.

Real-time sonoelastography of hepatic thermal lesions in a swine model.

Zhang M, Castaneda B, Christensen J, Saad W, Bylund K, Hoyt K, Strang JG, Rubens DJ, Parker KJ

Medical physics.. 2008 September 35 (9):4132-41. Epub 1900 01 01.

Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.

Bylund KC, Giampoli E, Singh D, Doerr T, Sahasrabudhe D, Liesveld J, Constine LS

Cancer investigation.. 2008 July 26 (6):638-41. Epub 1900 01 01.

Books

Reference Module in Biomedical Sciences (2016)

Chapter: 7-Benzylidine-7-Dehydronaltrexone

Authors: Bylund DB; Bylund K

Publisher: Elsevier 2016

Reference Module in Biomedical Sciences (2015)

Chapter: Endometrial Cancer

Authors: Bylund KC

Publisher: Elsevier 2015

Reference Module in Biomedical Sciences (2015)

Chapter: Testicular Cancer

Authors: Bylund KC

Publisher: Elsevier 2015

Reference Module in Biomedical Sciences (2015)

Chapter: Difenoxin

Authors: Bylund DB; Bylund K

Publisher: Elsevier 2015

Advances in Radiation Oncology in Lung Cancer (2011)

Chapter: Translational Research in Lung Cancer

Authors: Singh D; Bylund K; Chen Y

Publisher: Springer-Verlag GmbH, Heidelberg 2011

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

During this visit, did this provider spend enough time with you?

4.9

During this visit, did this provider show respect for what you had to say?

4.9

During this visit did this provider give you easy to understand information about these health questions or concerns?

4.9

During this visit, did this provider listen carefully to you?

4.9

During this visit, did this provider explain things in a way that was easy to understand?

4.9

Patient Comments

I have already highly recommended Dr. Bylund to others.

Aug 10, 2024

5.0

Dr. Bylund is very gentle. Has very good bed manners. Listen well and includes me in recommended treatments. He is the best. Trust him with my care totally.

Apr 23, 2024

5.0

I have recommended Dr. Bylund to others. He is exceptional and is supported by a well informed team.

Feb 24, 2024

5.0

Calming professional approach to presented issues with personal' interest concern and ability to ease tension.

Feb 19, 2024

5.0

Provider was very knowledgeable, courteous and professional.

Jan 29, 2024

5.0

Dr. Bylund is an excellent doctor, and is very helpful with answering questions, and giving advice.

Jan 23, 2024

It was nice to have my son, an LPN and Director for a medical research firm, attending on the call. Dr Bylund received and answered all of our questions in a concerned and professional manner. The results of his opinion and his comments were quickly shared with both my Urologist and Radiation Oncologist who I have since been in contact with.

Nov 29, 2023

5.0

Dr. Bylund is a very knowledgeable and concerned Doctor. He always answers the questions honestly and he has empathy, good human being,

Oct 09, 2023

5.0

Dr. Kevin Bylund is a super capable & kind MD.

Jul 18, 2023

4.2

Excellent visit

Jun 01, 2023

5.0

No problems!

May 17, 2023

5.0

I have recommended Dr. Bylund to other people and they are now patients.

May 04, 2023

5.0

The provider is a very experienced and knowledge doctor.

Apr 25, 2023

5.0

Dr Bylund is one of the best in his field..! I'm gratful for his imput & care of my treatments

Mar 18, 2023

Dr. Bylund did a great job explaining my treatment options and clearly addressed my concerns regarding treatment side effects. He was clearly appreciative of my travel issues (I live 2 1/2 hours away from Rochester).

Mar 05, 2023

5.0

Dr. Bylund was very professional, knowledgable and complete, in explaining the results of the scans [...]

Feb 28, 2023

5.0

Showed compassion. Listened to me. Explained everything with simple words.

Feb 27, 2023

Dr. Bylund was very clear of explaining procedures and what to expect with our next appt.

Feb 12, 2023

5.0

Everyone I have met so far have been the best and I am very grateful.

Jan 27, 2023

5.0

Dr. Bylund gave succinct and clear information. He gave us the cordinating services for my complex case. I did not receive name and/or number to call for further Information, clarification. It would be greatly helpful to reduce patient anxiety for serious matters. That would be of great help to me.

Jan 11, 2023

5.0

Dr Bylund is a very compassionate doctor

Jan 07, 2023

5.0

Very informative! My questions were answered in a thoughtful and caring perspective.

Jan 06, 2023

5.0

Dr. Bylund always makes an extra effort to be certain. I am comfortable and informed. Simply put: he is exceptional in all aspects of the patient/doctor process.

Dec 21, 2022

5.0

First rate! Compassionate, caring & knowledgeable.

Dec 20, 2022

5.0

Dr. Bylund, always listens to my feedback from treatments, never pushy.

Nov 30, 2022

5.0

Dr. Bylund is a consummate professional. Other than my primary I feel Dr. Bylund has the greatest knowledge of my history and always asks about how things are going with some long term concerns. I'd recommend him to anyone. Incredibly caring.

Nov 17, 2022

5.0

Dr. Bylund is an excellent, caring doctor.

Nov 13, 2022

5.0

Dr. was always understanding cannot say enough good about the doctor concern. [...]. Very good - Very very good.

Oct 04, 2022

5.0

I have already recommended Kevin to others. I have the highest regard for him.

Sep 19, 2022

5.0

Fantastic group of people in this office

Sep 15, 2022

5.0

Dr. Bylund & his team got A+.

Aug 19, 2022

5.0

Great experience.

Aug 18, 2022

5.0

Very impressed with the [...] we spent explaining the cancer treatment approach they recommended. I definitely feel that they care and their confidence is very reassuring

Aug 17, 2022

5.0

I have the greatest respect for the dr.

May 11, 2022

5.0

The provider had shown the vast experience and knowledge, as well as his erudition in adjacent medical fields -

Apr 22, 2022

5.0

Bylund and his team are excellent.

Mar 03, 2022